Medical and cosmetic dermatology often overlap, says dermatologist and DERM 2023 faculty member Gilly Munavalli, MD. Along with fellow faculty member Suneel Chilukuri, MD, he discussed basic aesthetic interventions that may be appropriate for most practices. They...
As the field of biologic and small molecule therapies has taken shape and grown in the last two decades, so has the role of the Biologic Coordinator or Access Specialist. Across multiple medical specialties, Biologic Coordinators fill an administrative role in the...
Kristine Kucera, PA-C, MPAS, DHS The World Health Organization declared October 10 Mental Health Day. With this, they acknowledged the hidden burdens of skin disease. A large survey focused on patients suffering from dermatological conditions showed that mental...
Global access to care for psoriatic disease, “remains fragmented and challenging,” according to the International Federation of Psoriatic Disease Associations (IFPA). “Access for All,” the theme of World Psoriasis Awareness Day 2023, is intended to highlight the need...
Bringing together more than 100 attendees, the latest DEF Biologic and Small Molecule NP/PA CME Bootcamp in Dallas last month provided up to the minute information about advanced treatment approaches for common inflammatory skin diseases and practical guidance for...
Bimzelx® (bimekizumab-bkzx) from UCB is now FDA approved for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is the first and only approved psoriasis treatment designed to selectively inhibit...
